Judge in Its Own Cause: Should a Lab Be Allowed to Approve Its Own Animal Experiments?

The Judge It Removes, Not the Speed It Buys

Imagine you are a senior official at the CCSEA. Your desk is full of applications from research institutions that want to start experiments on animals. Scientists complain that central approvals take too long, that useful research waits in a queue and that most of these experiments are low-risk anyway.

The draft rules offer you a clean solution: let each institution's own ethics committee approve anything rated mild or moderate and keep only severe experiments for yourself. The easy answer would be to call this efficiency.

But that answer leaves out who now decides.

Why the

critics have a point Under the draft, the institution that wants to run an experiment also decides how severe it is and so whether anyone outside will review it. That is a classic conflict of interest. The old principle of natural justice, nemo judex in causa sua, says no one should judge their own cause.

Here, the institution is effectively both applicant and judge. The animals cannot object or appeal. Bentham's utilitarian test asks whether a being can suffer, not whether it can argue. That makes independent oversight more important, not less.

Maneka Gandhi's group put it in practical terms: if independent oversight is weakened, who protects the animals? The draft also sits awkwardly beside other policy. In 2023, the Health Ministry amended the New Drugs and Clinical Trials Rules to allow non-animal methods such as organ-on-chip systems and computer models.

Globally, the EU's Directive 2010/63/EU builds on the 3Rs (Replacement, Reduction, Refinement) and the US removed its blanket animal-testing mandate in December 2022. Loosening oversight runs against that direction.

Why "ease of research" deserves a fair hearing The other side is not careless.

A central committee reviewing every experiment can become a bottleneck that slows useful science. Most experiments are not severe. The draft also keeps safeguards: institutional committees have nine members, including socially aware external members and the draft itself says it aims to integrate the 3Rs.

Risk-based regulation, with lighter oversight for lower risk, is a normal and reasonable tool. So both sides cost something. Strict central review costs time and research capacity. Self-certification costs independence and the price is paid by beings who cannot speak.

The resolution:

certify, then audit If you were the official, the defensible decision is neither the old queue nor full self-certification. It is a middle design:

• Let institutional committees approve mild and moderate experiments, but only with a written justification that no non-animal method can do the job, linking approvals to the 2023 rules.
• Require the CCSEA to audit a random sample of approvals and every borderline severity classification, with the power to suspend a committee that misclassifies.
• Publish summary data on approvals by severity. This gives up some speed and adds work for the CCSEA. That is the honest cost. But it keeps an independent judge in the system, which is the one thing the draft as written removes.

For the exam: good regulation can be risk-based without being self-certified. The question is never only how fast, but who checks the one who decides.